铝佐剂通过NLRP3炎症小体和髓系非粒细胞改善新生小鼠脓毒症生存
本研究在新生小鼠多微生物脓毒症模型中,探讨铝盐佐剂预处理诱导宿主保护性免疫的机制。通过遗传学和细胞清除研究显示,预防性给予铝佐剂改善脓毒症生存,该作用依赖NLRP3炎症小体激活和树突状细胞活化,并需要髓系非粒细胞Gr1阳性细胞及MyD88信号通路。作者认为铝基疫苗佐剂可能具有预防新生儿脓毒症发生和改善病死率的治疗前景。
要点
- 在新生小鼠多微生物脓毒症模型中,预防性给予铝佐剂可改善脓毒症生存。
- 该保护作用依赖NLRP3炎症小体激活和树突状细胞活化。
- 该有益效应依赖髓系非粒细胞Gr1阳性细胞及MyD88信号通路激活。
- 作者认为铝基疫苗佐剂可能具有预防新生儿脓毒症和改善病死率的治疗前景。
适用人群与场景
- 新生小鼠多微生物脓毒症模型;早产(<37周)和低出生体重(<2,500 g)婴儿是新生儿脓毒症死亡风险最高的人群。
研究设计与关键结果
- 研究利用遗传学和细胞清除研究,在新生小鼠中证明预防性给予铝佐剂通过激活NLRP3炎症小体和树突状细胞活化改善脓毒症生存。
- 该有益效应依赖髓系非粒细胞Gr1阳性细胞和MyD88信号通路激活。
证据类型、等级与局限
- 研究类型:动物实验(新生小鼠多微生物脓毒症模型),采用遗传学和细胞清除研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为铝基疫苗佐剂可能具有预防新生儿脓毒症发生和改善这一高危人群病死率的治疗前景。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Neonatal sepsis leads to significant morbidity and mortality with the highest risk of death occurring in preterm (<37 weeks) and low birth weight (<2,500 g) infants. The neonatal immune system is developmentally immature with well-described defects in innate and adaptive immune responses. Immune adjuvants used to enhance the vaccine response have emerged as potential therapeutic options, stimulating non-specific immunity and preventing sepsis mortality. Aluminum salts ("alum") have been used as immune adjuvants for over a century, but their mechanism of action remains poorly understood. This study aims to identify potential mechanisms by which pretreatment with alum induces host protective immunity to polymicrobial sepsis in neonatal mice. Utilizing genetic and cell-depletion studies, we demonstrate here that the prophylactic administration of aluminum adjuvants in neonatal mice improves sepsis survival via activation of the nucleotide oligomerization domain-like receptor family, pyrin-domain-containing 3 inflammasome and dendritic cell activation. Furthermore, this beneficial effect is dependent on myeloid, non-granulocytic Gr1-positive cells, and MyD88-signaling pathway activation. These findings suggest a promising therapeutic role for aluminum-based vaccine adjuvants to prevent development of neonatal sepsis and improve mortality in this highly vulnerable population.
参考来源
- Rincon JC, Hawkins RB, Hollen M, et al. Aluminum Adjuvant Improves Survival Via NLRP3 Inflammasome and Myeloid Non-Granulocytic Cells in a Murine Model of Neonatal Sepsis. Shock. 2021. PMID: 32769820. doi:10.1097/SHK.0000000000001623
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。